Bionomics Limited, a global, clinical stage biopharmaceutical company, is pleased to announce that it plans to conduct a registered initial public offering of American Depositary Shares in the United States and a concurrent listing of ADSs on Nasdaq.
August 2, 2021
· 4 min read